Canton Strategic Holdings (CNTN) Enterprise Value (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Enterprise Value of -$41.5 million for Q1 2026, down 3760.12% on a YoY basis from $1.1 million in Q1 2025, and down 143.84% quarter-over-quarter from -$17.0 million in Q4 2025.
Canton Strategic Holdings (CNTN) Enterprise Value (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Enterprise Value for 7 years, with the latest figure at -$41.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 3760.12% year-over-year to -$41.5 million; the trailing twelve-month figure through Mar 2026 stood at -$41.5 million (down 3760.12% YoY), and the FY2025 full-year result was -$17.0 million, down 378.53% from the prior year.
- Enterprise Value for Q1 2026 stood at -$41.5 million, down from -$17.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.1 million in Q1 2025, with the low at -$41.5 million in Q1 2026.
- Historically, Enterprise Value has averaged -$8.8 million across 5 years, with a median of -$7.6 million in 2022.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 149361.29% — and 2025, when it soared 87.23%.
- Canton Strategic Holdings' Enterprise Value stood at -$6.5 million in 2022, then tumbled by 67.96% to -$10.9 million in 2023, then soared by 67.45% to -$3.6 million in 2024, then tumbled by 378.53% to -$17.0 million in 2025, then plunged by 143.84% to -$41.5 million in 2026.
- The last three Enterprise Value figures came in at -$41.5 million (Q1 2026), -$17.0 million (Q4 2025), and -$7.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -41.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.53 Mn |
| Dec 31, 2025 | -17.03 Mn |
| Sep 30, 2025 | -7.61 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | -3.56 Mn |
| Sep 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -8.43 Mn |
| Dec 31, 2023 | -10.94 Mn |
| Sep 30, 2023 | -2.69 Mn |
| Jun 30, 2023 | -3.90 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -6.51 Mn |
| Sep 30, 2022 | -7.60 Mn |
| Jun 30, 2022 | -9.48 Mn |
| Mar 31, 2022 | -11.12 Mn |
| Dec 31, 2021 | -4,356.00 |
| Sep 30, 2021 | -45,095.00 |
| Jun 30, 2021 | -29,271.00 |